The efficacy of boron neutron capture therapy for glioblastoma is significantly increased by a new nitrogen agent. The drug can be taken in low doses, is selectively absorbed by brain tumor cells, and improves blood retention. Positive results from studies on cell cultures, mice, and rats demonstrate the novel agent’s potential as a radiotherapy agent.
Efficient boron neutron capture therapy for brain tumor with novel boron carrier
